Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Intern Med

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    May 2021
  1. BENEDEK P, Jiao H, Duvefelt K, Skoog T, et al
    Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    J Intern Med. 2021 May 6. doi: 10.1111/joim.13287.
    PubMed     Abstract available

    November 2020
  2. VUORIO A, Kovanen PT
    PCSK9 inhibitors for COVID-19: An opportunity to enhance the antiviral action of interferon in patients with hypercholesterolemia.
    J Intern Med. 2020 Nov 21. doi: 10.1111/joim.13210.
    PubMed     Abstract available

    June 2020
  3. LEE JW, Choi EA, Kim YS, Kim Y, et al
    Statin exposure and the risk of dementia in individuals with hypercholesterolemia.
    J Intern Med. 2020 Jun 24. doi: 10.1111/joim.13134.
    PubMed     Abstract available

    May 2020
  4. KARADIMOU G, Gistera A, Gallina AL, Caravaca AS, et al
    Treatment with a Toll-like Receptor 7 ligand evokes protective immunity against atherosclerosis in hypercholesterolaemic mice.
    J Intern Med. 2020 May 14. doi: 10.1111/joim.13085.
    PubMed     Abstract available

    April 2020
  5. VUORIO A, Watts GF, Kovanen PT
    Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk.
    J Intern Med. 2020 Apr 3. doi: 10.1111/joim.13070.
    PubMed     Abstract available

    January 2020
  6. VUORIO A, Watts GF, Schneider WJ, Tsimikas S, et al
    Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.
    J Intern Med. 2020;287:2-18.
    PubMed     Abstract available

    December 2019
  7. BJORNSON E, Packard CJ, Adiels M, Andersson L, et al
    Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
    J Intern Med. 2019 Dec 17. doi: 10.1111/joim.13017.
    PubMed     Abstract available

  8. BAASS A, Paquette M, Bernard S, Hegele RA, et al
    Familial Chylomicronemia Syndrome: an under-recognized cause of severe hypertriglyceridemia.
    J Intern Med. 2019 Dec 16. doi: 10.1111/joim.13016.
    PubMed     Abstract available

    October 2019
  9. NARVERUD I, Christensen JJ, Bakke SS, Ulven SM, et al
    Profiling of immune-related gene expression in children with familial hypercholesterolemia.
    J Intern Med. 2019 Oct 21. doi: 10.1111/joim.13001.
    PubMed     Abstract available

    August 2019
  10. ERIKSSON M, Angelin B
    How to handle hypertriglyceridaemia in acute pancreatitis - Still a vote for conservatives?"
    J Intern Med. 2019 Aug 27. doi: 10.1111/joim.12971.
    PubMed     Abstract available

    July 2019
  11. GUNDUZ C, Basoglu OK, Hedner J, Bonsignore MR, et al
    Hyperlipidemia Prevalence and Cholesterol Control in Obstructive Sleep Apnea: Data from the European Sleep Apnea Database (ESADA).
    J Intern Med. 2019 Jul 1. doi: 10.1111/joim.12952.
    PubMed     Abstract available

    May 2019
  12. BERBERICH AJ, Ziada A, Zou GY, Hegele RA, et al
    Conservative management in hypertriglyceridemia-associated pancreatitis.
    J Intern Med. 2019 May 11. doi: 10.1111/joim.12925.
    PubMed     Abstract available

    July 2018
  13. BENEDEK P, Eriksson M, Duvefelt K, Freyschuss A, et al
    Genetic Testing for Familial Hypercholesterolemia among Survivors of Acute Coronary Syndrome.
    J Intern Med. 2018 Jul 5. doi: 10.1111/joim.12812.
    PubMed     Abstract available

    June 2017
  14. OLSSON AG, Angelin B, Assmann G, Binder CJ, et al
    Can LDL cholesterol be too low? Possible risks of extremely low levels.
    J Intern Med. 2017;281:534-553.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.